Search Results

There are 30063 results for: content related to: Clinical predictors of survival in men with castration-resistant prostate cancer

  1. Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer

    Cancer

    Volume 122, Issue 24, December 15, 2016, Pages: 3848–3855, Colette A. Whitney, Lauren E. Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris and Stephen J. Freedland

    Version of Record online : 9 AUG 2016, DOI: 10.1002/cncr.30221

  2. You have free access to this content
    Characterising the castration-resistant prostate cancer population: a systematic review

    International Journal of Clinical Practice

    Volume 65, Issue 11, November 2011, Pages: 1180–1192, M. Kirby, C. Hirst and E. D. Crawford

    Version of Record online : 14 OCT 2011, DOI: 10.1111/j.1742-1241.2011.02799.x

  3. Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer

    BJU International

    Volume 118, Issue 4, October 2016, Pages: 570–577, Stephen J. Freedland, Lauren E. Howard, Brian T. Hanyok, Vishnu K. Kadiyala, Jameson Y. Kuang, Colette A. Whitney, Floyd R. Wilks, Christopher J. Kane, Martha K. Terris, Christopher L. Amling, Matthew R. Cooperberg, William J. Aronson and Daniel M. Moreira

    Version of Record online : 8 FEB 2016, DOI: 10.1111/bju.13405

  4. You have free access to this content
    PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer

    International Journal of Urology

    Volume 21, Issue 12, December 2014, Pages: 1209–1214, Prabhakar Mithal, Emma Allott, Leah Gerber, Julia Reid, William Welbourn, Eliso Tikishvili, Jimmy Park, Adib Younus, Zaina Sangale, Jerry S Lanchbury, Steven Stone and Stephen J Freedland

    Version of Record online : 5 AUG 2014, DOI: 10.1111/iju.12571

  5. You have free access to this content
    Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy

    Cancer

    Volume 120, Issue 2, 15 January 2014, Pages: 197–204, Daniel M. Moreira, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, Paolo Boffetta and Stephen J. Freedland

    Version of Record online : 11 OCT 2013, DOI: 10.1002/cncr.28423

  6. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer

    Cancer

    Zachary Klaassen, Lauren E. Howard, Amanda de Hoedt, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris and Stephen J. Freedland

    Version of Record online : 27 DEC 2016, DOI: 10.1002/cncr.30505

  7. You have free access to this content
    Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue s1, October 2012, Pages: 14–22, Noel W. Clarke

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11430.x

  8. Variant allele of HSD3B1 increases progression to castration-resistant prostate cancer

    The Prostate

    Volume 75, Issue 7, May 15, 2015, Pages: 777–782, Gang Wu, Shengsong Huang, Kent L. Nastiuk, Jinliang Li, Jun Gu, Ming Wu, Qimin Zhang, Hanqing Lin and Denglong Wu

    Version of Record online : 1 MAR 2015, DOI: 10.1002/pros.22967

  9. You have free access to this content
    Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database

    Cancer

    Volume 122, Issue 2, January 15, 2016, Pages: 222–229, Brian T. Hanyok, Lauren E. Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Edwin M. Posadas and Stephen J. Freedland

    Version of Record online : 20 OCT 2015, DOI: 10.1002/cncr.29748

  10. You have free access to this content
    New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  11. You have free access to this content
    Clinical development of novel therapeutics for castration-resistant prostate cancer

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 299–308, Matthew D. Galsky, Alexander C. Small, Che-kai Tsao and William K. Oh

    Version of Record online : 24 APR 2012, DOI: 10.3322/caac.21141

  12. Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer

    The Journal of Pathology

    Volume 231, Issue 4, December 2013, Pages: 505–516, Roopika Menon, Mario Deng, Kerstin Rüenauver, Angela Queisser, Martin Pfeifer, Anne Offermann, Diana Boehm, Wenzel Vogel, Veit Scheble, Falko Fend, Glen Kristiansen, Nicolas Wernert, Nicole Oberbeckmann, Saskia Biskup, Mark A Rubin, Zaki Shaikhibrahim and Sven Perner

    Version of Record online : 12 NOV 2013, DOI: 10.1002/path.4274

  13. You have full text access to this OnlineOpen article
    Targeting the adaptive molecular landscape of castration-resistant prostate cancer

    EMBO Molecular Medicine

    Volume 7, Issue 7, July 2015, Pages: 878–894, Alexander W Wyatt and Martin E Gleave

    Version of Record online : 20 APR 2015, DOI: 10.15252/emmm.201303701

  14. You have free access to this content
    Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 8, October 2012, Pages: 1149–1155, Toshiki Kijima, Yasuhisa Fujii, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Fumitaka Koga, Hitoshi Masuda, Satoru Kawakami and Kazunori Kihara

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1464-410X.2012.10959.x

  15. You have free access to this content
    Abstracts

    BJU International

    Volume 111, Issue S1, April 2013, Pages: 13–119,

    Version of Record online : 27 MAR 2013, DOI: 10.1111/bju.12069

  16. The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer

    The Prostate

    Volume 75, Issue 12, September 1, 2015, Pages: 1247–1254, Zhibin Chen, Ni Chen, Pengfei Shen, Jing Gong, Xiang Li, Tao Zhao, Banghua Liao, Liangren Liu, Zhenhua Liu, Xingming Zhang, Jiyan Liu, Zhufeng Peng, Xueqin Chen, Miao Xu, Haojun Gui, Peng Zhang, Qiang Wei, Qiao Zhou and Hao Zeng

    Version of Record online : 27 APR 2015, DOI: 10.1002/pros.23005

  17. You have free access to this content
    Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications

    Cancer

    Volume 121, Issue 21, November 1, 2015, Pages: 3853–3861, Dana E. Rathkopf, Steven M. Larson, Aseem Anand, Michael J. Morris, Susan F. Slovin, David R. Shaffer, Glenn Heller, Brett Carver, Neal Rosen and Howard I. Scher

    Version of Record online : 15 JUL 2015, DOI: 10.1002/cncr.29578

  18. Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer

    The Prostate

    Volume 73, Issue 6, May 2013, Pages: 657–667, Anna Nordin, Wanzhong Wang, Karin Welén and Jan-Erik Damber

    Version of Record online : 5 NOV 2012, DOI: 10.1002/pros.22607

  19. Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer

    The Prostate

    Volume 72, Issue 14, 1 October 2012, Pages: 1491–1505, John T. Isaacs, Jason M. D'Antonio, Shuangling Chen, Lizamma Antony, Susan P. Dalrymple, Georges H. Ndikuyeze, Jun Luo and Samuel R. Denmeade

    Version of Record online : 6 MAR 2012, DOI: 10.1002/pros.22504

  20. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer

    The Prostate

    Volume 72, Issue 10, 1 July 2012, Pages: 1093–1103, Tong Sun, Ming Yang, Shaoyong Chen, Steven Balk, Mark Pomerantz, Chen-Lin Hsieh, Myles Brown, Gwo-Shu Mary Lee and Philip W. Kantoff

    Version of Record online : 29 NOV 2011, DOI: 10.1002/pros.22456